What is institutional overlap — and what it does not tell you
When several leading investors disclose the same company, it is worth understanding why. It is not a buy signal.
Capital Signals editorial team · 12 Oct 2026 · 5 min read
Who owns Elevance Health, Inc.? 4 of the investors we track held it at their latest disclosure: Harris Associates (Oakmark), The Baupost Group, Baillie Gifford, Ruane, Cunniff & Goldfarb.
Figures cover Capital Signals' tracked investors only — not the company's full shareholder register.
Tracked investors
4
in latest disclosures
New positions
0
Increased
1
Reduced
2
Exited (confirmed)
0
| Investor | Holding | Reported value | Portfolio weight | Activity | Reporting period | Source |
|---|---|---|---|---|---|---|
| Harris Associates (Oakmark) | 4.92m | $1.90bn | 2.5% | Increased | Q2 2026 Filed 14 Aug 2026 | |
| The Baupost Group | 1.28m | $495.8m | 9.8% | Unchanged | Q3 2026 Filed 13 Nov 2026 | |
| Baillie Gifford | 1.04m | $403.1m | 0.4% | Reduced | Q3 2026 Filed 9 Nov 2026 | |
| Ruane, Cunniff & Goldfarb | 975k | $379.0m | 6.2% | Reduced | Q3 2026 Filed 16 Nov 2026 |
Number of tracked investors whose most recent disclosure at each period end included Elevance Health, Inc..
| Period | Value |
|---|---|
| Q4 2025 | 0 |
| Q1 2026 | 1 |
| Q2 2026 | 4 |
| Q3 2026 | 4 |
Portfolio weight in each disclosure. “—” means not reported in that disclosure.
| Investor | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 |
|---|---|---|---|---|
| Harris Associates (Oakmark) | n/d | 1.9% | 2.5% | n/d |
| The Baupost Group | n/d | n/d | 9.1% | 9.8% |
| Baillie Gifford | n/d | n/d | 0.4% | 0.4% |
| Ruane, Cunniff & Goldfarb | n/d | n/d | 5.9% | 6.2% |
n/d: the investor did not publish a disclosure for that period.
An important qualification
When several leading investors disclose the same company, it is worth understanding why. It is not a buy signal.
Capital Signals editorial team · 12 Oct 2026 · 5 min read